Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players

Atherosclerosis

Volumn 222, Issue 2, 2012, Pages 551-556

  Virani, Salim S ^a,b   Pompeii, Lisa ^c   Lincoln, Andrew E ^d   Dunn, Reginald E ^d   Tucker, Andrew M ^d   Nambi, Vijay ^b   Nasir, Khurram ^e   Vogel, Robert A ^f   Boone, Jeffrey L ^g   Roberts, Arthur J ^h   Ballantyne, Christie M ^b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNION MEMORIAL HOSPITAL   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g Boone Heart Institute   (United States)

^h Living Heart Foundation   (United States)

Author keywords

Biomarkers; Cholesterol; Lipoproteins; Retired NFL players; Subclinical atherosclerosis

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; FOOTBALL; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PRIORITY JOURNAL; RETIREMENT; SCREENING;

ADULT; AGED; ASYMPTOMATIC DISEASES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CHOLESTEROL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FOOTBALL; HUMANS; LIPOPROTEINS, LDL; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; PREVALENCE; RETIREMENT; RISK ASSESSMENT; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER; UNITED STATES;

EID: 84861344997     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.03.031     Document Type: Article

References (29)

1. Brunzell J.D., Davidson M., Furberg C.D., et al. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2008, 51:1512-1524.
2. Contois J.H., McConnell J.P., Sethi A.A., et al. Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices. Clin Chem 2009, 55:407-419.
3. Cromwell W.C., Otvos J.D. Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100mg/dl. Am J Cardiol 2006, 98(December (12)):1599-1602.
4. Otvos J.D., Jeyarajah E.J., Cromwell W.C. Measurement issues related to lipoprotein heterogeneity. Am J Cardiol 2002, 90(October (8A)):22i-29i.
5. Cromwell W.C., Otvos J.D., Keyes M.J., et al. LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study-implications for LDL management. J Clin Lipidol 2007, 1(6):583-592.
6. Otvos J.D., Mora S., Shalaurova I., Greenland P., Mackey R.H., Goff D.C. Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. J Clin Lipidol 2011, 5(March-April (2)):105-113.
7. Davidson M.H., Ballantyne C.M., Jacobson T.A., et al. Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists. J Clin Lipidol 2011, 5(September (5)):338-367.
8. Hurst R.T., Burke R.F., Wissner E., et al. Incidence of subclinical atherosclerosis as a marker of cardiovascular risk in retired professional football players. Am J Cardiol 2010, 105:1107-1111.
9. Miller M.A., Croft L.B., Belanger A.R., et al. Prevalence of metabolic syndrome in retired National Football League players. Am J Cardiol 2008, 101:1281-1284.
10. Sattar N., Williams K., Sniderman A.D., D'Agostino R., Haffner S.M. Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study. Circulation 2004, 110:2687-2693.
11. Sniderman A.D., Scantlebury T., Cianflone K. Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann Intern Med 2001, 135:447-459.
12. Virani S.S., Catellier D.J., Pompeii L.A., et al. Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. Atherosclerosis 2011, 219:596-602.
13. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336:973-979.
14. 2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2004, 109:837-842.
15. Virani S.S., Polsani V.R., Nambi V. Novel markers of inflammation in atherosclerosis. Curr Atheroscler Rep 2008, 10:164-170.
16. Nambi V., Chambless L., Folsom A.R., et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol 2010, 55:1600-1607.
17. Hunt K.J., Sharrett A.R., Chambless L.E., et al. Acoustic shadowing on B-mode ultrasound of the carotid artery predicts CHD. Ultrasound Med Biol 2001, 27:357-365.
18. Chang A.Y., FitzGerald S.J., Cannaday J., et al. Cardiovascular risk factors and coronary atherosclerosis in retired National Football League players. Am J Cardiol 2009, 104:805-811.
19. Croft L.B., Belanger A., Miller M.A., Roberts A., Goldman M.E. Comparison of National Football League linemen versus nonlinemen of left ventricular mass and left atrial size. Am J Cardiol 2008, 102:343-347.
20. Albuquerque F.N., Kuniyoshi F.H., Calvin A.D., et al. Sleep-disordered breathing, hypertension, and obesity in retired National Football League players. J Am Coll Cardiol 2010, 56:1432-1433.
21. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
22. Jeyarajah E.J., Cromwell W.C., Otvos J.D. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 2006, 26:847-870.
23. Akaike H. Information theory as an extension of the maximal likelihood principle. 2nd International Symposium in Information Theory Akademiai Kiado 1973.
24. Rosenberg P.S., Katki H., Swanson C.A., et al. Quantifying epidemiologic risk factors using non-parametric regression: model selection remains the greatest challenge. Stat Med 2003, 22:3369-3381.
25. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
26. Mora S., Szklo M., Otvos J.D., et al. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007, 192:211-217.
27. Crouse J.R., Goldbourt U., Evans G., et al. Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 1996, 27:69-75.
28. Virani S.S. Non-HDL cholesterol as a metric of good quality of care: opportunities and challenges. Tex Heart Inst J 2011, 38:160-162.
29. Elliott P., Chambers J.C., Zhang W., et al. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 2009, 302:37-48.